MedPath

Sumatriptan

Sumatriptan 100mg Tablet

Approved
Approval ID

f1a118cf-2179-572a-e053-2995a90acbb0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 12, 2023

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sumatriptan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0224
Application NumberANDA078327
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sumatriptan
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 12, 2023
FDA Product Classification

INGREDIENTS (1)

SUMATRIPTAN SUCCINATEActive
Quantity: 100 mg in 1 1
Code: J8BDZ68989
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sumatriptan - FDA Drug Approval Details